ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 331 filers reported holding ROYALTY PHARMA PLC in Q4 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,501,468 | -8.8% | 202,707 | +3.3% | 0.02% | 0.0% |
| Q2 2023 | $6,030,051 | -10.5% | 196,163 | +4.9% | 0.02% | -15.0% |
| Q1 2023 | $6,739,880 | -19.4% | 187,063 | -11.6% | 0.02% | -25.9% |
| Q4 2022 | $8,366,226 | -10.6% | 211,696 | -9.1% | 0.03% | -10.0% |
| Q3 2022 | $9,361,000 | -19.8% | 232,985 | -16.1% | 0.03% | -3.2% |
| Q2 2022 | $11,679,000 | +20.2% | 277,808 | +11.4% | 0.03% | +55.0% |
| Q1 2022 | $9,714,000 | +40.0% | 249,333 | +43.1% | 0.02% | +53.8% |
| Q4 2021 | $6,941,000 | +71.6% | 174,187 | +55.6% | 0.01% | +62.5% |
| Q3 2021 | $4,046,000 | -5.7% | 111,965 | +7.0% | 0.01% | -11.1% |
| Q2 2021 | $4,289,000 | -9.0% | 104,624 | -3.2% | 0.01% | -10.0% |
| Q1 2021 | $4,713,000 | +74.8% | 108,042 | +100.6% | 0.01% | +66.7% |
| Q4 2020 | $2,696,000 | +461.7% | 53,870 | +371.7% | 0.01% | +500.0% |
| Q3 2020 | $480,000 | – | 11,420 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $92,052,204 | 47.04% |
| Indie Asset Partners, LLC | 433,000 | $11,751,620 | 11.84% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,095,745 | $111,158,519 | 6.01% |
| Advanced Portfolio Management, LLC | 230,000 | $6,242,200 | 5.25% |
| Compound Global Advisors, LLC | 626,412 | $17,000,822 | 3.73% |
| Geo Capital Gestora de Recursos Ltd | 135,079 | $3,666 | 3.39% |
| TORRAY INVESTMENT PARTNERS LLC | 412,633 | $11,198,860 | 1.98% |
| Overbrook Management Corp | 298,712 | $8,107,044 | 1.89% |
| Silicon Valley Community Foundation | 358,270 | $9,723,448 | 1.18% |
| Greytown Advisors Inc. | 74,601 | $2,024,671 | 1.12% |